© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - CEO of the Month, Belgium: Jan De Backer, FLUIDDA
Posted 28th October 2015

CEO of the Month, Belgium: Jan De Backer, FLUIDDA

FLUIDDA develop proprietary diagnostics for lung diseases, such as asthma, chronic obstructive pulmonary disease and lung fibrosis.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

CEO of the Month, Belgium: Jan De Backer, FLUIDDA

CEO of the Month – Jan De Backer, FLUIDDA

Image

FLUIDDA develop proprietary diagnostics for lung diseases, such as asthma, chronic obstructive pulmonary disease (COPD) and lung fibrosis. The technology, called Functional Respiratory Imaging or FRI is a combination of high-resolution CT scans and computer methods that simulate the flow in the lungs.

FRI provides an unparalleled insight into how the lungs of specific patients work. Airways, blood vessels and airflow can be visualised and analysed in great detail. In addition, FRI can determine where inhaled drug particles end up in the lungs of patients. FLUIDDA uses FRI to help pharmaceutical companies develop better drugs for lung diseases, faster and cheaper. Additionally the firm also work with individual physicians to help them to select the most appropriate treatment for specific patients, which is unusual as it requires a more costly trial and error approach not usually adopted by other firms in the industry.

Jan started at the company in 2005 and has since helped the firm to differentiate itself from its competitors by becoming active in the R&D phase of development, where their technology can inform pharmaceutical and biotech companies very quickly whether the compound is worthwhile pursuing.

The firm are also involved in the marketing phase where their visualisations of the mode of action of the drug, based on real patient data, is used to show the added value of the drug or device to doctors, insurance companies as well as being active in clinical practice where the company can leverage the knowledge from the clinical trials to assist the doctor in selecting the most optimal treatment for individual patients based on the patient specific characteristics.

Jan explained the firm’s vision and how he ensures that this is upheld by everyone within the firm.
“My role as CEO has evolved over the years. I started the company ten years ago and at that time the emphasis of the company was mainly on the development of the technology. We had to perform our clinical validation trials and ensure the technology became scalable. Gradually my role became more general management with the focus on international expansion (we opened an office in India in 2010 and in the US in 2012) and developing a vision for sustained growth.

“This vision, nowadays, revolves very much around levering modern day technology to improve the efficiency, including the cost/benefit ratio, of many facets of the healthcare system. This includes drug development, treatment optimization in clinical practice and even patient education. We feel that a system where all stakeholders align around the patient interest is a system with the highest probability of success to improve the efficiency of the healthcare system.

“Communication is key to ensure that everyone in the company is aware of our vision and that they do whatever is needed to support it. Despite a very busy travel schedule I try to keep in touch with the teams in the different locations as much as possible. Every month I update the company, including our directors, on the latest developments. This is good opportunity to either welcome people to the team, congratulate the teams on the performance or to caution for potential threats in the foreseeable future. Our people know that if there is an issue they can always bring it my attention and I will do whatever I can to resolve it.”

Being a technology company in the healthcare industry means being exposed to a number of rapidly changing markets, with regulation, technology and health innovation constantly evolving. Jan described the market and how the changes affected FLUIDDA.

“I strongly believe that we are on the verge of a revolution in healthcare. We see important stakeholders such as governments, patient advocacy groups and a new generation of doctors all converge around implementing new technologies to make the system more efficient. This is largely driven by the budgetary constraints due to the exponential increase in the healthcare costs and the additional challenges in healthcare due to the aging population.

“As a company we have invested greatly in being able to translate, often complex, technology into a format fit for the medical world. We do not expect doctors to become technical experts but we rather make our technology as accessible as possible for the physician. We like to harness the power of modern technology such as high-performance computing and big data and convert that into personalised medicine in collaboration with the medical professionals. FLUIDDA aims to do that in a sustainable manner, which should ensure our position as a leading edge technology partner.”

Overall, Jan made it clear that these changes in the industry, now and in the future, would keep the firm at the very height of innovation.

“This is an exciting time for healthcare. There is a high need to change to keep the system affordable. At the same time, the level of implementation of modern technology (cloud services, home monitoring, personalised diagnostics, etc) is relatively low. Companies that manage to implement this type of new technology will have a bright future. Within FLUIDDA we will strive to be one of those companies by continuing to transform excellent science into readyto- use applications for doctors and researchers.”

Company: FLUIDDA

Name: Jan De Backer

Email: [email protected]

Web: www.FLUIDDA.com

Address: Groeningenlei 132,

2550 Kontich, Belgium

Telephone: +32 3 450 87 20

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Is Your Retail Job Safe? What AI and ChatGPT Mean for the Retail Industry
Innovation
01/03/2023Is Your Retail Job Safe? What AI and ChatGPT Mean for the Retail Industry

ChatGPT, the new AI-powered chatbot, is set to revolutionise the way we work. The chatbot uses natural language processing (NLP) to generate high-quality, human-like responses upon user request, making it one of the most innovative and influential AI systems t

Read Full PostRead - Eye Icon
4 Tips For Automating Your Business Security Successfully
Innovation
08/09/20224 Tips For Automating Your Business Security Successfully

According to Statistica, 47.3% of companies are embracing automation from a security perspective. If you’re looking to automate your business’ security successfully, you need an awareness of the tools and technologies most beneficial for security automatio

Read Full PostRead - Eye Icon
Quick off the Mark: Intuit Inc Acquires KDK Softwares Private Limited
Innovation
25/03/2015Quick off the Mark: Intuit Inc Acquires KDK Softwares Private Limited

Intuit Inc. is a software company that develops financial and tax preparation software and related services for small businesses, accountants and individuals. We spoke to Nikhil Arora, Vice President and Managing Director at Intuit India, on the landmark deal

Read Full PostRead - Eye Icon
Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Innovation
18/02/2020Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21

Read Full PostRead - Eye Icon
Green Data Centers: How Sustainable Practices Are Shaping the Industry
News
07/11/2024Green Data Centers: How Sustainable Practices Are Shaping the Industry

Green Data Centers: How Sustainable Practices Are Shaping the Industry In the recent past, there has been increased use of data centers as more firms embarked on cloud services, artificial intelligence, and data storage. Although tremendous improvements exist

Read Full PostRead - Eye Icon
Awesome Approyo
Leadership
23/11/2020Awesome Approyo

Businesses in the modern world have had to experience unparalleled transformation unlike many other times that have gone before. Companies have had to transform their business processes, and Approyo has been hard at work helping them do just that. Approyo spec

Read Full PostRead - Eye Icon
Over 35 Years of Sensational Success
Legal
17/01/2023Over 35 Years of Sensational Success

Complex litigation law can be extremely challenging to navigate however, with a strong, level-headed load of experience, we find ourselves in good hands with Marc J. Bern & Partners LLP.

Read Full PostRead - Eye Icon
Five Things to Outsource for Your Business
News
06/01/2023Five Things to Outsource for Your Business

With running a business, there’s a balance between overhead and profit. Your overhead needs to be low enough to maximise profit, but you also need to invest enough back into your company to grow. One method a lot of businesses use to strike this balance is o

Read Full PostRead - Eye Icon
How to Identify and Prevent a Cyber Attack
Innovation
13/01/2023How to Identify and Prevent a Cyber Attack

Cyber threats and risks are evolving at an increasingly rapid scale. Businesses everywhere are failing to react quickly enough to malicious cyber attacks, and as such, they can suffer irreparable damage to finances, systems, data and reputation.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow